U Kunzendorf1, T Pohl, S Bulfone-Paus
1Department of Internal Medicine and Nephrology, Universitätsklinikum Benjamin Franklin, Berlin, Germany.
New chimeric proteins offer targeted immunosuppression for preventing autoimmune diseases and kidney transplant rejection. These fusion proteins, like tumor necrosis factor (TNF)-receptor IgG, show promise in clinical settings.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: